1 – 10 of 158
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2022
- Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics (2022) ADVANCED DRUG DELIVERY REVIEWS. 184.
- 2021
- Unexpected effects of a selective and potent c-MET inhibitor in an immunocompetent intraductal model for triple-negative breast cancer (2021) OncoDot.3 symposium, Abstracts.
- Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics : getting the message across (2021) ADVANCED DRUG DELIVERY REVIEWS. 176.
- Low-dose single-shot COVID-19 mRNA vaccines lie ahead (2021) MOLECULAR THERAPY. 29(6). p.1944-1945
- In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation (2021) MOLECULAR THERAPY. 29(3). p.1164-1173
- Mucosal vaccination against periodontal disease : current status and opportunities (2021) FRONTIERS IN IMMUNOLOGY. 12.
- Antibody-mediated targeting of antigens to intestinal aminopeptidase N elicits gut IgA responses in pigs (2021) FRONTIERS IN IMMUNOLOGY. 12.
- Squaric ester-based, pH-degradable nanogels : modular nanocarriers for safe, systemic administration of toll-like receptor 7/8 agonistic immune modulators (2021) JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 143(26). p.9872-9883
- Corticosteroids and mRNA vaccines : a word of caution (2021) MOLECULAR THERAPY. 29(3). p.893-894
- Sterilizing immunity against SARS‐CoV‐2 infection in mice by a single‐shot and lipid amphiphile imidazoquinoline TLR7/8 agonist‐adjuvanted recombinant spike protein vaccine** (2021) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 60(17). p.9467-9473